Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated...

Difficult Conversations, the Need for Culturally Competent Care, and Why Representation...

Archetypes, Individuation, and the Shadow: Carl Jung’s Enduring Psychedelic Influence

Vital 4: Informational Session and Q+A, with David

Vital 4: Informational Session and Q+A, with Diego

Vital 4: Informational Session and Q+A, with Kyle

Vital 4: Informational Session and Q+A, with David

Dutch Committee Seeks to Expedite MDMA-Assisted Therapy for PTSD

Ayahuasca Traditions Abroad: Forest Medicine in the International Diaspora

Load more